Cg Oncology Inc. (CGON) Live Share Price, Invest From India

Cg Oncology Inc. Stock Performance

as on March 28, 2026 at 6:59 am IST

Day's Low
Day's High
$64.15
Day's Price Range
$67.63
$64.64
0.76%
Downside
4.63%
Upside
52 Week's Low
52 Week's High
$14.80
52-Week Price Range
$69.35
$64.64
77.10%
Downside
7.29%
Upside

Cg Oncology Inc. share price movements today

Previous Close: $66.67
Open: $66.88
Volume: 829.0K
Day's Low - High: $64.15 - $67.63
52 Week Low - High: $14.80 - $69.35

Cg Oncology Inc. Historical Returns

1 Month Return: + 9.9 %
3 Month Return: + 62.2 %
1 Year Return: + 144.59 %
3 Year Return: 0 %
5 Year Return: 0 %

Cg Oncology Inc. Stock Fundamentals & Key Indicators

Check Cg Oncology Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$5.6B

EPS (TTM)

-2.3998

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-189.3M

Revenue (TTM)

4.0M

Profit Margin

0.00%

Return On Equity TTM

-21.67%

Cg Oncology Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Cg Oncology Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Cg Oncology Inc.	BUY	$5.6B	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$43.5B	132.92%	140.84	8.45%
Vertex Pharmaceuticals Incorporated	BUY	$115.2B	101.77%	29.58	32.94%
Beone Medicines Ltd	NA	$31.8B	NA	112.58	5.37%
Regeneron Pharmaceuticals, Inc.	BUY	$80.0B	54.69%	18.25	31.41%

Stock Returns calculator for Cg Oncology Inc. Stock including INR - Dollar returns

The Cg Oncology Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Cg Oncology Inc. investment value today

Current value as on today

₹2,55,172

Returns

₹1,55,172

(+155.17%)

Returns from Cg Oncology Inc. Stock

₹1,44,663 (+144.66%)

Dollar Returns*

₹10,509 (+10.51%)

Analyst Recommendation on Cg Oncology Inc. Stock

Based on 11 analysts

BUY

81.82%

Buy

18.18%

Hold

0.00%

Sell

Based on 11 analysts, 81.82% of analysts recommend a 'BUY' rating for Cg Oncology Inc.. Average target price of $83.29

Cg Oncology Inc. Share Price Target

Get share price movements and forecasts by analysts on Cg Oncology Inc..

What analysts predicted

22.39%UPSIDE

Target Price

$83.29

Current Price

$64.64

Analyzed by

11 Analysts

Target

$83.29

Cg Oncology Inc. target price $83.29, a slight upside of 22.39% compared to current price of $64.64. According to 11 analysts rating.

Cg Oncology Inc. Stock’s Investor Sentiment and Interest

Search interest for Cg Oncology Inc. Stock has increased by 133% in the last 30 days, reflecting an upward trend in search activity.

Time period: February 26, 2026 to March 28, 2026

Change:133% versus previous 30 day period

Cg Oncology Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	0	0	0	0	0	0	0	-	1	2
Gross Profit	-11	0	0	0	0	0	0	0	0	0
Operating Income	-14	-18	-22	-25	-28	-38	-42	-48	-51	-48
EBITDA	-14	-18	-22	-25	-28	-38	-42	-41	-43	-40
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	-	0	0	0	0
Income Before Tax	-11	-16	-16	-18	-20	-31	-34	-41	-43	-41
Income Tax Expense	-2	-	-	-	-	-	-	-	-	-
Net Income	-11	-16	-16	-18	-20	-31	-34	-41	-43	-41
Net Profit Margin	-130755.56%	-1611600.00%	-3200.76%	-17028.83%	-47453.49%	-6973.25%	-66253.85%	0.00%	-2629.53%	-1779.03%

Cg Oncology Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	10	0	0	1	4
Gross Profit	10	0	0	1	0
Operating Income	-12	-35	-55	-114	-190
EBITDA	-12	-35	-55	-114	-159
Interest Expense	0	0	6	-	-
Depreciation	0	0	0	0	1
Income Before Tax	-12	-35	-48	-88	-160
Income Tax Expense	-	-	-	-	-
Net Income	-12	-35	-48	-88	-160
Net Profit Margin	-123.95%	-18556.54%	-23826.96%	-7729.50%	-3985.02%

Cg Oncology Inc. Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-16	-16	-18	-20	-31	-34	-41	-43	-41
Operating Cash Flow	-16	-26	-16	-15	-20	-29	-27	-38	-36
Investing Cash Flow	16	-307	-36	32	10	-186	1	15	-75
Financing Cash Flow	-2	402	0	2	223	0	0	54	99
Change in Cash	-2	69	-52	18	213	-215	-26	30	-12

Cg Oncology Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-35	-48	-88	-160
Operating Cash Flow	-29	-45	-78	-132
Investing Cash Flow	-55	-121	-300	-245
Financing Cash Flow	119	86	628	153
Change in Cash	34	-79	248	-224

Insights on Cg Oncology Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 1 month, CGON stock has moved up by 9.9%
POSITIVE IMPACT
Best in 1 Year
In the last 1 year, CGON has outperformed top 5 stocks with highest market-cap in its industry

About Cg Oncology Inc.

CG Oncology, Inc. is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. The Company’s product candidate, cretostimogene grenadenorepvec (cretostimogene) is in clinical development for the treatment of patients with non-muscle invasive bladder cancer (NMIBC). Its BOND-003 is in Phase III clinical trial, which is designed to assess the safety and efficacy of cretostimogene in high-risk Bacillus Calmette Guerin (BCG)-unresponsive NMIBC when administered as a monotherapy. Its CORE-001 is a Phase II single-arm, open-label clinical trial of cretostimogene administered with BCG-unresponsive NMIBC. Its portfolio also includes PIVOT-006, a Phase III trial to assess the safety and efficacy of adjuvant cretostimogene when administered as monotherapy to patients with intermediate-risk NMIBC following transurethral resection of the bladder tumor (TURBT).

Organisation	Cg Oncology Inc.
Headquarters	400 Spectrum Center Drive, Irvine, CA, United States, 92618
CEO	Mr. Arthur Kuan
E-voting on shares	Click here to vote

Key Management of Cg Oncology Inc.

Name	Title
Mr. Joshua F. Patterson	General Counsel, Chief Compliance Officer & Secretary
Dr. Vijay Kasturi M.D.	Chief Medical Officer
Mr. James M. DeTore	Interim Principal Financial & Accounting Officer
Mr. Swapnil Bhargava Ph.D.	Chief Technical Officer
Ms. Amy Steele	Vice President of Finance & Administration
Ms. Sarah Connors	Vice President of Communications & Patient Advocacy
Mr. Bing Kung	Vice President of Corporate Development
Mr. Arthur Kuan	Chairman & CEO
Mr. Ambaw Bellete M.S.	President & COO

FAQs

What is Cg Oncology Inc. share price today?

Cg Oncology Inc. share price today is $64.64 as on March 28, 2026 at 1:29 am IST at the close of the market. Cg Oncology Inc. share today touched a day high of $67.63 and a low of $64.15.

What is the 52 week high and 52 week low for Cg Oncology Inc. share?

Cg Oncology Inc. share touched a 52 week high of $69.35 on March 17, 2026 and a 52 week low of $14.8 on April 9, 2025. Cg Oncology Inc. stock price today i.e. March 28, 2026 at 1:29 am IST is closed at $64.64,which is 6.79% down from its 52 week high and 336.76% up from its 52 week low.

What is Cg Oncology Inc.'s market capitalisation today?

Cg Oncology Inc. market capitalisation is $0.01T as on March 28, 2026 at 1:29 am IST.

How to invest in Cg Oncology Inc. Stock (CGON) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Cg Oncology Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cg Oncology Inc. Shares that will get you 0.0232 shares as per Cg Oncology Inc. share price of $64.64 per share as on March 28, 2026 at 1:29 am IST.

What is the minimum amount required to buy Cg Oncology Inc. Stock (CGON) from India?

Indian investors can start investing in Cg Oncology Inc. (CGON) shares with as little as ₹94.651 or $1 (as of March 28, 2026 at 3:41 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹946.51 in Cg Oncology Inc. stock (as per the Rupee-Dollar exchange rate as on March 28, 2026 at 3:41 pm IST). Based on Cg Oncology Inc. share’s latest price of $64.64 as on March 28, 2026 at 1:29 am IST, you will get 0.1547 shares of Cg Oncology Inc.. Learn more about fractional shares .